Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Mycobacterium bovis Osteomyelitis Involving a Hip Arthroplasty after Intravesicular Bacille Calmette-Guérin for Bladder Cancer

Carmen E. Guerra, Robert F. Betts, Regis J. O'Keefe and Jack W. Shilling
Clinical Infectious Diseases
Vol. 27, No. 3 (Sep., 1998), pp. 639-640
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4460598
Page Count: 2
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
Preview not available
Preview not available

Abstract

Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is one of the most effective agents in the treatment of superficial bladder cancer. BCG osteomyelitis is an infrequent complication of intravesicular BCG therapy; only five cases of BCG vertebral osteomyelitis have been reported in the literature. Similarly, the infection of an indwelling extravascular device by BCG is rare; there is only one previous report documenting infection associated with an automated implantable cardiac defibrillator. We report a case of BCG osteomyelitis involving a hip arthroplasty that occurred after intravesicular administration of BCG for bladder cancer, and we review the risk factors predisposing to such infections and their treatment.

Page Thumbnails

  • Thumbnail: Page 
639
    639
  • Thumbnail: Page 
640
    640